Skip Navigation


Annals of Oncology Advance Access originally published online on June 21, 2005
Annals of Oncology 2005 16(11):1845; doi:10.1093/annonc/mdi354
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/11/1845    most recent
mdi354v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pitini, V.
Right arrow Articles by La Torre, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitini, V.
Right arrow Articles by La Torre, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes

The first 10% of the full text of this article appears below.

We read with interest the recent article by Stathopoulos et al. [1Go] in the February 2005 issue of Annals of Oncology in which they reported that CK19 mRNA-positive cells in the peripheral . . . [Full Text of this Article]

V. Pitini*, C. Arrigo, C. Amata and I. La Torre

Department of Medical Oncology, University of Messina, Messina, Italy

* E-mail: pitini@ciaoweb.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?